Chemoprevention

Subscribe to Selected New Research on Chemoprevention

6217 relevant articles (402 outcomes, 1336 trials/studies) found for this Therapy

Description: The use of chemical compounds to prevent the development of a specific disease.

Also Known As:

Chemoprophylaxis

Relationship Network

Therapy Context: Research Results

Therapeutics: 5232

Drug Therapy: 116925

Chemoprevention: 6217

Antibiotic Prophylaxis: 2333

Experts

1.	Thompson, Ian M: 15 articles (04/2008 - 01/2003)
2.	Mukhtar, Hasan: 13 articles (07/2008 - 01/2002)
3.	Khuri, Fadlo R: 11 articles (01/2008 - 01/2002)
4.	Steele, Vernon E: 9 articles (09/2008 - 08/2002)
5.	Lippman, Scott M: 9 articles (03/2008 - 10/2003)
6.	Lippman, S M: 9 articles (09/2001 - 03/2000)
7.	Jordan, V Craig: 8 articles (11/2007 - 01/2002)
8.	Lieberman, R: 8 articles (12/2001 - 02/2000)
9.	Kong, Ah-Ng Tony: 7 articles (09/2008 - 01/2006)
10.	Alberts, David S: 7 articles (05/2008 - 03/2002)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2006 - "Since most studies on these drugs were conducted on animal models or cell culture, further studies are needed to determine the efficacy of these drugs in chemoprevention of human cancers." 06/01/2000 - "A recent human intervention trial showed that daily supplementation with selenized yeast (Se-yeast) led to a decrease in the overall cancer morbidity and mortality by nearly 50%; past research has also demonstrated that selenized garlic (Se-garlic) is very effective in mammary cancer chemoprevention in the rat model" 09/01/2006 - "The development of new drugs for the control of these targets that are both safe and effective will be important for the future of cancer chemoprevention." 10/01/2005 - "The development of new drugs for the control of these targets that are both safe and effective will be important for the future of cancer chemoprevention." 03/01/2000 - "In this short article, we review the conceptual basis for chemoprevention of cancer, the proven clinical efficacy of this concept, and current trends to develop new chemopreventive agents based on understanding of their mechanisms of action" Order ALL the reference details at left...
2.	Malaria 01/01/2004 - "Chemoprophylaxis is highly effective in reducing mortality and morbidity from malaria in young children and pregnant women living in endemic areas, but is difficult to sustain and, in some studies, has impaired the development of naturally acquired immunity" 10/01/1998 - "Yet, most of travelers' diseases such as malaria cannot be prevented by vaccination and appropriate preventive measures (chemoprophylaxis and protection against insects) should be taken." 11/01/1994 - "The harmful effects of malaria are most pronounced during first pregnancies and chemoprophylaxis is most effective when given at this time" 11/01/1989 - "Among these, malaria represent the most alarming problem, both because of the incidence cases and the difficulties related to the efficacy of pharmacological remedies for the chemoprophylaxis" 12/14/1979 - "Tourists should not forget that a rational and regular chemoprophylaxis is the best protection against serious attacks of malaria." Order ALL the reference details at left...
3.	Infection 09/01/1994 - "These data indicate that chemoprophylaxis is highly effective in preventing primary PCP and improving survival time in infants with human immunodeficiency virus-1 infection." 01/01/2007 - "However, the QFT test was not helpful for reducing the indication of chemoprophylaxis because the infection rates were very high in our case" 10/01/2003 - "Further study in larger populations is needed to explore whether antifungal chemoprophylaxis or other strategies may be effective in preventing fungal infection in high-risk neonates" 08/01/1999 - "OBJECTIVE: Intrapartum chemoprophylaxis has resulted in a significant reduction of group B Streptococcus neonatal infection" 05/01/1998 - "The adequate treatment and chemoprophylaxis of these infections has improved the prognosis of their evolution, although they still present a high morbidity and mortality when they occur" Order ALL the reference details at left...
4.	Breast Neoplasms (Breast Cancer) 06/17/2004 - "Further studies are warranted to elucidate the efficacy of chemoprevention in women at a very high risk of breast cancer, e.g" 11/01/2006 - "Positive results of several recent clinical trials for preventing breast cancer in high-risk populations suggest that chemoprevention is a rational and attractive strategy." 11/10/2004 - "The purpose of our study was to review the evidence for the efficacy of surveillance for early detection, bilateral prophylactic mastectomy, prophylactic oophorectomy and chemoprevention in preventing breast cancer and improving survival of BRCA1 or BRCA2 carriers" 01/01/2006 - "The third-generation, AIs, hold a great promise in chemoprevention of breast cancer" 04/01/2008 - "OBJECTIVES: The study aim is to describe interest in breast cancer chemoprevention among older women without a history of breast cancer and to determine whether aging-related factors such as diminished life expectancy, increasing comorbidity and medication burden attenuate chemoprevention interest" Order ALL the reference details at left...
5.	Prostatic Neoplasms (Prostate Cancer) 03/01/2006 - "At this time, nothing has been proven effective as chemoprevention against clinically significant prostate cancer." 01/01/2002 - "There are a number of moderate to high-risk cohorts and clinical models of primary and secondary prevention that can be employed in both short-term developmental (translational) trials for proof of biologic activity and in intermediate sized longer-term chemoprevention trials for proof of efficacy against prostate cancer" 04/01/2001 - "In addition to the higher incidence of prostate cancer among African Americans compared with other populations, the mortality of prostate cancer among this high-risk population is significantly greater than 100% compared with other populations, thus further demonstrating the need for chemoprevention in this target population" 10/20/2000 - "Television and news print media are effective in recruiting potential participants in a prostate cancer chemoprevention trial." 01/01/2006 - "Active research into chemoprevention is ongoing and gathered evidence will provide effective and safe strategies to prevent prostate cancer" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Tamoxifen
2.	Retinoids
3.	Chloroquine (Aralen)
4.	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
5.	Aspirin (Acetylsalicylic Acid)
6.	Isoniazid (Ftivazide)
7.	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
8.	Biological Markers (Surrogate Marker)
9.	Fenretinide
10.	beta Carotene (Betacarotene)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Transplantation (Transplant Recipients)
3.	Hysterectomy
4.	Immunotherapy
5.	Transplants (Transplant)

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 18531 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>